Jun 29, 2026
18 MIN READ

Ozempic Dosing Schedule: Step-by-Step Guide

Semaglutide injection follows a 4-week titration phase before reaching maintenance dosing. PlexusDx explains each weekly step, how your dose advances, and what to expect during treatment.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 29, 2026
18 MIN READ

ozempic dosing schedule: step-by-step guide — PlexusDx GLP-1 education

Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection has become one of the most prescribed GLP-1 medications for weight management, with clinical trials showing an average weight loss of 15% over 68 weeks. Understanding how your dose progresses is essential for optimizing results and minimizing side effects. PlexusDx provides compounded semaglutide injections starting at $149/month, with personalized dosing guidance throughout your treatment journey.

How Semaglutide Injection Dosing Works

Semaglutide injection is administered subcutaneously once per week, typically on the same day each week. Unlike oral medications that require daily dosing, the weekly format improves compliance and simplifies the treatment routine. Your healthcare provider will determine an individualized dosing plan based on your medical history, current weight, and metabolic goals.

The medication comes pre-filled in pen or vial form and is injected into the abdomen, thigh, or upper arm. Most patients rotate injection sites weekly to minimize tissue irritation. PlexusDx works with licensed 503A compounding pharmacies to prepare pharmaceutical-grade semaglutide, ensuring consistent quality and potency for each injection.

Week-by-Week Semaglutide Titration Schedule

Week 1 begins with a standard starting dose of 0.25 mg injected once weekly. This introductory dose allows your body to adapt to the medication while gauging your tolerability and response. Most patients experience mild gastrointestinal effects during this first week, including reduced appetite and subtle nausea that typically resolves within days.

Week 5 marks the transition to a 0.5 mg weekly dose, which is the first major step in the titration phase. Your provider monitors your weight loss progress and symptom profile before advancing further. Weeks 9 and 13 typically involve increases to 1.0 mg and 1.7 mg respectively, with each four-week interval allowing tissue adaptation and appetite regulation to stabilize.

After week 13, most patients reach their target maintenance dose between 1.7 mg and 2.4 mg weekly. Some individuals benefit from a maximum dose of 2.4 mg, while others achieve optimal results at lower maintenance levels. The key principle is that your dose may advance as your tolerance improves, but your monthly cost with PlexusDx remains flat—your price won't change as your dose increases.

Factors That Influence Your Semaglutide Dosing Plan

Your genetics play a significant role in how effectively semaglutide works for weight loss. The Precision Peptide Genetic Test offered by PlexusDx analyzes key variants including GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—each affecting peptide signaling pathways that influence appetite suppression and metabolic rate. Patients with certain genetic profiles may see faster results at lower doses, while others benefit from advancing more quickly through the titration schedule.

Kidney and liver function also guide dosing adjustments, as semaglutide is processed through the kidneys and liver. Your provider may recommend a slower titration schedule if you have existing kidney or liver concerns. Additionally, your starting weight, age, concurrent medications, and metabolic conditions like type 2 diabetes can influence how aggressively your dose increases during the first 13 weeks.

Gastrointestinal tolerance is another critical factor that your provider monitors at each dosing milestone. Some patients experience nausea or constipation during titration, which may warrant a slower advancement schedule or dietary modifications. PlexusDx providers evaluate your symptom reports and blood work regularly to optimize your dose without unnecessary discomfort.

Expected Weight Loss Timeline and Maintenance Dosing

Clinical evidence shows that meaningful weight loss typically begins around week 4, with patients averaging a 2-3 pound reduction during the first month. By week 12, most individuals report a cumulative weight loss of 5-8 pounds, with more significant reductions accelerating after reaching the 1.7 mg maintenance dose. The complete 68-week clinical trial demonstrated sustained weight loss, with benefits continuing as long as treatment continues.

Maintenance dosing typically begins after week 13 and continues indefinitely, with your weekly 1.7-2.4 mg injection remaining constant unless your provider determines an adjustment is needed. Many patients maintain their weight loss for years with consistent weekly injections and lifestyle modifications supporting metabolic health. PlexusDx provides ongoing clinical support and progress monitoring at a flat monthly rate, ensuring you stay accountable throughout your weight loss journey.

Semaglutide Injection vs. Oral Formulations

Semaglutide injection provides superior bioavailability compared to oral tablets, meaning your body absorbs and utilizes more of the active medication. Oral semaglutide requires specific timing relative to meals and other medications to maximize absorption, whereas injections bypass gastrointestinal variables entirely. For patients seeking consistent, predictable dosing outcomes, weekly injections often outperform oral alternatives.

PlexusDx offers both compounded semaglutide injection (starting at $149/month) and oral semaglutide (starting at $249/month), allowing you to choose based on your preferences and lifestyle. Injection therapy typically delivers weight loss results 10-15% faster than oral formulations in real-world practice. Your PlexusDx provider will discuss which format aligns best with your goals, medical history, and comfort level with self-injection.

Important Safety Considerations During Dosing

Semaglutide carries a black box warning for personal or family history of thyroid cancer and multiple endocrine neoplasia type 2 (MEN2), making pre-treatment screening essential. You should not use semaglutide if you have a history of medullary thyroid cancer or MEN2 syndrome. Before starting, your provider reviews your complete medical history to ensure semaglutide is safe for your individual circumstances.

Pancreatitis, though rare, represents a serious potential side effect requiring immediate medical attention if you experience severe abdominal pain. Dehydration risk increases during the initial titration phase, particularly if nausea leads to reduced fluid intake. PlexusDx providers educate all patients on warning signs and encourage regular hydration, especially during the first 8-12 weeks of treatment.

Drug interactions may occur if you take oral diabetes medications or certain blood pressure drugs, as semaglutide intensifies their effects. Your provider adjusts concurrent medications as needed when starting semaglutide. Regular blood work monitoring ensures your kidney function, liver markers, and blood glucose levels remain stable throughout your dosing journey.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I skip a dose or adjust my semaglutide injection schedule on my own?

No—you should never skip doses or alter your weekly injection schedule without consulting your PlexusDx provider. Missing doses can reduce appetite suppression and slow weight loss progress. If you miss an injection by less than two days, take it as soon as possible; if more than two days have passed, skip that dose and resume your regular schedule the following week.

What does the clinical evidence show about semaglutide weight loss outcomes?

The STEP trial demonstrated that patients receiving semaglutide 2.4 mg weekly lost an average of 15% of body weight over 68 weeks, compared to 2.7% in the placebo group. Approximately 86% of participants achieved clinically significant weight loss (≥5%), with sustained benefits continuing through maintenance dosing. Real-world data from PlexusDx patients aligns closely with these clinical trial results.

How much does semaglutide injection cost with PlexusDx, and is it HSA/FSA eligible?

PlexusDx compounded semaglutide injection starts at $149/month and remains flat regardless of your dose tier—your price won't increase as your dose advances. Yes, semaglutide is HSA/FSA eligible, and PlexusDx accepts these benefits at checkout. No insurance is required, and there are no hidden membership fees or per-dose surcharges.

Are nausea and gastrointestinal side effects permanent, or do they fade during titration?

Most patients experience mild nausea during weeks 1-4, which typically resolves within 3-7 days as your body adapts. Some experience mild symptoms intermittently through week 13, but the majority report significant improvement once maintenance dosing begins. Eating smaller meals, staying hydrated, and taking anti-nausea medication (if approved by your provider) can minimize discomfort during titration.

Can the Precision Peptide Genetic Test predict whether I'll respond well to semaglutide?

Yes—the PlexusDx Precision Peptide Genetic Test analyzes 150+ genetic insights across 14 metabolic pathways, including GLP1R and GIPR variants that directly influence semaglutide responsiveness. The test costs $99 as an add-on after your first month of treatment and helps your provider optimize your dosing schedule and predict potential weight loss magnitude. Patients with favorable genetic profiles often see faster results at lower maintenance doses.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves